Poster Session C - Monday Afternoon
Category: Colon
Antony Mathew, MD
The University of Texas Health Science Center at Houston
Houston, TX
Table 1: Appendicitis-related characteristics of the study patients (n=10) | |
Characteristic | No. of patients (%) |
Median no. of ICI doses (IQR) | 4 (2-15) |
Clinical symptoms |
|
Abdominal pain | 7 (70) |
Diarrhea | 0 |
Fever | 4 (40) |
Nausea/vomiting | 3 (30) |
Loss of appetite | 3 (30) |
CT findings |
|
Appendiceal inflammation | 10 (100) |
Abscess/fluid collection | 2 (20) |
Perforation | 1 (10) |
Complications of appendicitis |
|
Abscess | 2 (20) |
Perforation | 1 (10) |
Treatment of appendicitis |
|
No treatment | 0 |
Antibiotics | 5 (50) |
Antibiotics plus surgery/IR procedure | 5 (50) |
ICI therapy termination due to appendicitis | 2 (20) |
Cancer treatment after ICI therapy termination |
|
No further cancer treatment | 0 |
Switched to other non-ICI treatment | 1 (10) |
Outcomes |
|
Hospitalization | 10 (100) |
Median length of hospitalization, days (IQR) | 9 (2-11) |
Response of appendicitis after any treatment | 9 (90) |
Median follow-up duration, months (IQR) | 28.5 (14.0-35.5) |
All-cause mortality | 3 (30) |